ask="2.60"
ask_size="2600"
average_daily_volume="61519"
bid="1.03"
bid_size="4000"
book_value="0.95"
change="-0.01"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-0.64"
change_From_52_week_low="0.22"
change_in_percent="-0.73%"
close="1.36"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.75"
ebitda="-28.78M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-1.07"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.43"
high_52_weeks="2.00"
last_trade_date="1/30/2017"
last_trade_price="1.36"
last_trade_size="250"
last_trade_time="3:59pm"
low="1.33"
low_52_weeks="1.14"
market_capitalization="52.55M"
moving_average_200_day="1.40"
moving_average_50_day="1.27"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="1.39"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.81%"
percent_change_from_50_day_moving_average="+6.68%"
percent_change_from_52_week_high="-32.00%"
percent_change_from_52_week_low="+19.30%"
previous_close="1.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.45"
price_per_sales="6.87"
revenue="7.70M"
shares_outstanding="38640000"
short_ratio="1.90"
stock_exchange="NMS"
symbol="AVIR"
volume="90137"
weeks_range_52="1.14 - 2.00"
